P–230 The NAD+ precursor nicotinamide riboside protects against postovulatary aging in vitro
Authors: Tianjie L 
Published: August 2021

Study question

Can nicotinamide riboside, one of the NAD+ precursor, protect against postovulatary aging in vitro?

Summary answer

The NAD+ precursor nicotinamide riboside can protect against postovulatary aging in vitro.

What is known already

Postovulatory aging(POA) has been considered one of the most intractable challenges that limit the successful rate of ART. Multiple cellular and molecular changes have been involved during the process of POA. The NAD+ is a prominent redox cofactor which is indispensable to DNA repair, energy metabolism, autophagy, genomic stability as well as epigenetic homeostasis. Over the last several decades, increasingly studies have eported that NAD+ contents decline with age across multiple tissues and loss of it are implicated in various diseases associated to aging. As one of a precursor of NAD+, nicotinamide riboside play important role in regulating oxidative stress.

Study design, size, duration

In this study, we take advantage of in vitro aging model to explore the influences of NR administration on the postovulatory aged oocytes in mice. We analyzed the association of NR supplementation with the aging-related deterioration of oocyte quality, such as mitochondrial dysfunction, mislocalization of cortical granules, followed by embryonic development potential and the NAD+/SIRT1 signaling. We used 3582 oocytes totally.

Participants/materials, setting, methods

CD–1 mice oocytes/ in vitro culture/ UPLC-MS/MS for NAD+ contents measurement ,DCFH-DA staining for ROS detecting, γH2AX staining for DNA damage measurement, BODIPY FL ATP staining for ATP detecting, LCA-FITC staining to assess the distribution and dynamics of cortical granules (CGs), In vitro fertilization, Quantitative real time PCR

Main results and the role of chance

NR supplementation exerted protective effects on morphological defects of oocytes, and that these protective effects were concentration dependent. We detected a significantly decline in NAD+ levels in aging oocytes, however, NAD+ accumulation was present in aging oocytes after 200μM NR treatment, indicating that NR administration might be a feasible strategy to enhance the quality of aging oocytes. Furthermore, NR indeed elevated the embryonic development potential of POA oocytes after fertilization. Our findings revealed that NR administration effectively ameliorated ROS accumulation in POA oocytes.Then we tried to uncover the effects of NR on the meiotic apparatus in aging oocytes. NR supplementation can partially restores normal spindle assembly and chromosome alignment in postovulatory aging oocytes. Furthermore, we investigated the protective effects of NR on mitochondrial function through following expects: mitochondrial distribution, ATP production and mitochondrial membrane potential. NR treatment could promote mitochondrial function in oocytes during postovulatory aging in vitro. In addition, DNA damage and mislocalized CGs during postovulatory aging might be rescued by the supplementation of NR. Based on these evidences, we identified that NR improved the quality of aging oocytes by NAD+/SIRT1 axis.

Limitations, reasons for caution

Only in vitro, shown only in mice.

Wider implications of the findings: Our work represents a clinically effective pharmacological chemical to improve infertility caused by POA process. Further studies are needed to define the related mechanisms of NR supplementation on oocyte quality as well as reproductive outcomes clinically.

Trial registration number

N